Linezolid for XDR-TB - Final study outcomes

Myungsun Lee, Sangnae Cho, Clifton E. Barry

Research output: Contribution to journalLetter

38 Citations (Scopus)
Original languageEnglish
Pages (from-to)290-291
Number of pages2
JournalNew England Journal of Medicine
Volume373
Issue number3
DOIs
Publication statusPublished - 2015 Jul 16

Fingerprint

Linezolid
Acetamides
Extensively Drug-Resistant Tuberculosis
Antitubercular Agents
Oxazolidinones
Protein Synthesis Inhibitors
Sputum
Mycobacterium tuberculosis
Outcome Assessment (Health Care)

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Lee, Myungsun ; Cho, Sangnae ; Barry, Clifton E. / Linezolid for XDR-TB - Final study outcomes. In: New England Journal of Medicine. 2015 ; Vol. 373, No. 3. pp. 290-291.
@article{64e002e4848a4aa38ae734bd54ae8da2,
title = "Linezolid for XDR-TB - Final study outcomes",
author = "Myungsun Lee and Sangnae Cho and Barry, {Clifton E.}",
year = "2015",
month = "7",
day = "16",
doi = "10.1056/NEJMc1500286",
language = "English",
volume = "373",
pages = "290--291",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "3",

}

Linezolid for XDR-TB - Final study outcomes. / Lee, Myungsun; Cho, Sangnae; Barry, Clifton E.

In: New England Journal of Medicine, Vol. 373, No. 3, 16.07.2015, p. 290-291.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Linezolid for XDR-TB - Final study outcomes

AU - Lee, Myungsun

AU - Cho, Sangnae

AU - Barry, Clifton E.

PY - 2015/7/16

Y1 - 2015/7/16

UR - http://www.scopus.com/inward/record.url?scp=84937027327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937027327&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1500286

DO - 10.1056/NEJMc1500286

M3 - Letter

VL - 373

SP - 290

EP - 291

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 3

ER -